Pureos Bioventures
- Roger Nitsch
CEO and President of Neurimmune; key opinion leader in neurodegenerative diseases; developer of aducanumab (Alzheimer’s disease) now in partnership with Biogen. Part-time professor at the Institute for Regenerative Medicine, University of Zurich.
Links
Org chart
This person is not in the org chart
Teams
This person is not in any teams
Offices
This person is not in any offices